10 Short Squeeze Candidates To Watch This Week: Getty, Lannett, AirSculpt And More
Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move.
High short interest and a high cost to borrow are among the common traits that could lead to a short squeeze.
12 Consumer Discretionary Stocks Moving In Friday’s After-Market Session
Gainers Worksport (NASDAQ:WKSP) stock rose 6.7% to $1.75 during Friday’s after-market session. The company’s market cap stands at…
12 Consumer Discretionary Stocks Moving In Tuesday’s After-Market Session
Gainers Elys Game Technology (NASDAQ:ELYS) stock increased by 40.6% to $0.36 during Tuesday’s after-market session. Today’s trading volume…
12 Consumer Discretionary Stocks Moving In Wednesday’s Intraday Session
Gainers Cenntro Electric Group (NASDAQ:CENN) stock moved upwards by 20.8% to $0.47 during Wednesday’s regular session. Trading volume…
‘Hacker Claims To Have 400 Million Twitter Accounts For Sale’ – Apple Insider
https://appleinsider.com/articles/22/12/27/hacker-claims-to-have-400-million-twitter-accounts-for-sale
A hacker has recently claimed to have the data of 400 million Twitter accounts and is offering it for sale, although
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday’s Mid-Day Session
Gainers
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.
12 Consumer Discretionary Stocks Moving In Monday’s Intraday Session
Gainers Wag Group (NASDAQ:PET) shares moved upwards by 39.1% to $2.99 during Monday’s regular session. Trading volume for…
12 Consumer Discretionary Stocks Moving In Friday’s After-Market Session
Gainers Nogin (NASDAQ:NOGN) shares rose 32.0% to $0.66 during Friday’s after-market session. The company’s market cap stands at…
Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday’s Mid-Day Session
Gainers
Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share.